AMG-315

• Description :

  AMG-315 is a selective and potent CB1 agonist with a Ki of 7.8 nM and an EC50 of 0.6 nM. AMG-315 can significantly inhibit the cAMP production induced by Forskolin (HY-15371) with the maximum inhibitory effect reaching 76%. AMG-315 has significant stability against all endogenous cannabinoid hydrolases and oxidases. AMG-315 increases the mechanical withdrawal threshold in CFA (HY-153808) -induced inflammatory pain model. AMG-315 can be used for the research of inflammation[1].

• CAS Number :

  [2244425-65-6]

• UNSPSC :

  12352211

• Target :

  Cannabinoid Receptor

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Field of Research :

  Inflammation/Immunology

• Smiles :

  CCCCC/C=C\[C@H](C)/C=C\C/C=C\C/C=C\CCCC(N[C@H](C)CO)=O

• Molecular Formula :

  C24H41NO2

• Molecular Weight :

  375.59

• References & Citations :

  [1]Liu Y, et al. (R) -N- (1-Methyl-2-hydroxyethyl) -13- (S) -methyl-arachidonamide (AMG315) : a novel chiral potent endocannabinoid ligand with stability to metabolizing enzymes[J]. Journal of medicinal chemistry, 2018, 61 (19) : 8639-8657.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  CB1